You’re invited! Please join us on twitter Wednesday, May 2nd at 12pm ET for a tweetchat hosted by The Coalition for Clinical Trial Awareness.
I'll be at the #CTAW2018 Tweetchat on Wed 5/2 at 9amPT | 12pmET. Join me! Click To Tweet
Editor’s Note: This post was created by the Coalition for Clinical Trial Awareness (CCTA) to highlight the Clinical Trials Awareness Week Policy Roundtable that they hosted on May 3, 2017.
Patients are eager for new and better treatments, yet more than one-third of clinical trials do not meet their enrollment goals. Finding solutions to this challenge served as the focus of the third annual Clinical Trials Awareness Week, held May 1-5, 2017. At a May 3 policy roundtable held at the United States Capitol, diverse stakeholders explored how the federal government can help to raise clinical trials awareness. Participants included:
The event also featured U.S. Representative Diana Degette, a health policy leader and sponsor of the 21st Century Cures Act. The event’s discussion produced four key concepts for improving clinical trials awareness.
In an April 2017 letter to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce, CCTA encouraged members to use the Prescription Drug User Fee Act reauthorization process to:
Learn more about Clinical Trials Awareness Week 2017 at www.CCTAwareness.org.
This panel will discuss the ways that the federal government can raise the public’s awareness of the benefits of clinical trials. Attendees will hear from diverse stakeholders including patients, advocates, researchers, and policymakers. Through robust conversation, the panel will highlight specific ways that the government can address low participation in clinical trials through the creation of public-private partnerships.
RSVP here.
Please check back soon as we work to build more resources.
